pharmacists as part of an "early warning system" to help identify problems with newly approved drugs

Dear Pharmacist: You'll hear about a proposal to rely more on pharmacists as part of an "early warning system" to help identify problems with newly approved drugs.

In the last three years, several drugs had to be taken off the market...Prepulsid, Redux, Pondimin, Seldane, Roxiam, etc.

The HPB and FDA currently rely on voluntary reports to monitor new drugs for adverse reactions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote